146 related articles for article (PubMed ID: 15312141)
1. Allergen-independent immunostimulatory sequence oligodeoxynucleotide therapy attenuates experimental allergic rhinitis.
Rhee CS; Libet L; Chisholm D; Takabayashi K; Baird S; Bigby TD; Lee CH; Horner AA; Raz E
Immunology; 2004 Sep; 113(1):106-13. PubMed ID: 15312141
[TBL] [Abstract][Full Text] [Related]
2. Airway peptidoglycan and immunostimulatory DNA exposures have divergent effects on the development of airway allergen hypersensitivities.
Chisholm D; Libet L; Hayashi T; Horner AA
J Allergy Clin Immunol; 2004 Mar; 113(3):448-54. PubMed ID: 15007346
[TBL] [Abstract][Full Text] [Related]
3. Immunostimulatory sequence oligdeoxynucleotide/cholera toxin B conjugate: a novel allergen-independent intranasal vaccine for allergic rhinitis.
Won TB; Quan SH; Kim DY; Rhee CS; Lee CH
Ann Allergy Asthma Immunol; 2009 Apr; 102(4):314-22. PubMed ID: 19441603
[TBL] [Abstract][Full Text] [Related]
4. Vaccinations with T-helper type 1 directing adjuvants have different suppressive effects on the development of allergen-induced T-helper type 2 responses.
Trujillo-Vargas CM; Mayer KD; Bickert T; Palmetshofer A; Grunewald S; Ramirez-Pineda JR; Polte T; Hansen G; Wohlleben G; Erb KJ
Clin Exp Allergy; 2005 Aug; 35(8):1003-13. PubMed ID: 16120081
[TBL] [Abstract][Full Text] [Related]
5. Immunostimulatory oligodeoxynucleotide from Bifidobacterium longum suppresses Th2 immune responses in a murine model.
Takahashi N; Kitazawa H; Iwabuchi N; Xiao JZ; Miyaji K; Iwatsuki K; Saito T
Clin Exp Immunol; 2006 Jul; 145(1):130-8. PubMed ID: 16792683
[TBL] [Abstract][Full Text] [Related]
6. Intranasal administration of CpG oligodeoxynucleotides reduces lower airway inflammation in a murine model of combined allergic rhinitis and asthma syndrome.
Li HT; Zhang TT; Chen ZG; Ye J; Liu H; Zou XL; Wang YH; Yang HL
Int Immunopharmacol; 2015 Sep; 28(1):390-8. PubMed ID: 26163938
[TBL] [Abstract][Full Text] [Related]
7. Intranasal immunotherapy is more effective than intradermal immunotherapy for the induction of airway allergen tolerance in Th2-sensitized mice.
Takabayashi K; Libet L; Chisholm D; Zubeldia J; Horner AA
J Immunol; 2003 Apr; 170(7):3898-905. PubMed ID: 12646659
[TBL] [Abstract][Full Text] [Related]
8. Suppression of allergic response by CpG motif oligodeoxynucleotide-house-dust mite conjugate in animal model of allergic rhinitis.
Mo JH; Park SW; Rhee CS; Takabayashi K; Lee SS; Quan SH; Kim IS; Min IY; Raz E; Lee CH
Am J Rhinol; 2006; 20(2):212-8. PubMed ID: 16686392
[TBL] [Abstract][Full Text] [Related]
9. Listeriolysin O derived from Listeria monocytogenes inhibits the effector phase of an experimental allergic rhinitis induced by ovalbumin in mice.
Yamamoto K; Kawamura I; Tominaga T; Nomura T; Ito J; Mitsuyama M
Clin Exp Immunol; 2006 Jun; 144(3):475-84. PubMed ID: 16734617
[TBL] [Abstract][Full Text] [Related]
10. Systemic administration of olygodeoxynucleotides with CpG motifs at priming phase reduces local Th2 response and late allergic rhinitis in BALB/c mice.
Hayashi T; Hasegawa K; Sasaki Y
Inflammation; 2008 Feb; 31(1):47-56. PubMed ID: 17849181
[TBL] [Abstract][Full Text] [Related]
11. A prophylactic effect of an oligodeoxynucleotide containing a cytidine-guanosine motif against Japanese cedar pollen-induced T-helper type 2 allergic response.
Liu B; Zhang L; Liu J; Shan F; Wang E; Kimura Y
J Asthma; 2011 Nov; 48(9):974-8. PubMed ID: 21967528
[TBL] [Abstract][Full Text] [Related]
12. Modulation of murine allergic rhinosinusitis by CpG oligodeoxynucleotides.
Hussain I; Jain VV; Kitagaki K; Businga TR; O'Shaughnessy P; Kline JN
Laryngoscope; 2002 Oct; 112(10):1819-26. PubMed ID: 12368622
[TBL] [Abstract][Full Text] [Related]
13. Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity.
Tighe H; Takabayashi K; Schwartz D; Van Nest G; Tuck S; Eiden JJ; Kagey-Sobotka A; Creticos PS; Lichtenstein LM; Spiegelberg HL; Raz E
J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):124-34. PubMed ID: 10887315
[TBL] [Abstract][Full Text] [Related]
14. Needleless intranasal administration of HVJ-E containing allergen attenuates experimental allergic rhinitis.
Yasuoka E; Oshima K; Tamai K; Kubo T; Kaneda Y
J Mol Med (Berl); 2007 Mar; 85(3):283-92. PubMed ID: 17072578
[TBL] [Abstract][Full Text] [Related]
15. Effect of oral administration of CpG ODN-OVA on WBB6F1-W/Wv mice.
Teshima R; Okunuki H; Sato Y; Akiyama H; Maitani T; Sawada J
Allergol Int; 2006 Mar; 55(1):43-8. PubMed ID: 17075285
[TBL] [Abstract][Full Text] [Related]
16. Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice.
Broide D; Schwarze J; Tighe H; Gifford T; Nguyen MD; Malek S; Van Uden J; Martin-Orozco E; Gelfand EW; Raz E
J Immunol; 1998 Dec; 161(12):7054-62. PubMed ID: 9862743
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of allergen-loaded macrophages by TLR9-ligand potentiates IL-10-mediated suppression of allergic airway inflammation in mice.
Vissers JL; van Esch BC; Jeurink PV; Hofman GA; van Oosterhout AJ
Respir Res; 2004 Nov; 5(1):21. PubMed ID: 15538945
[TBL] [Abstract][Full Text] [Related]
18. Immunostimulatory oligodeoxynucleotide induces TH1 immune response and inhibition of IgE antibody production to cedar pollen allergens in mice.
Kohama Y; Akizuki O; Hagihara K; Yamada E; Yamamoto H
J Allergy Clin Immunol; 1999 Dec; 104(6):1231-8. PubMed ID: 10589006
[TBL] [Abstract][Full Text] [Related]
19. Mice vaccinated with allergen-pulsed myeloid dendritic cells are not protected from developing allergen-induced Th2 responses.
Trujillo-Vargas CM; Ramirez-Pineda JR; Palmetshofer A; Grunewald S; Moll H; Berberich C; Erb KJ
Int Arch Allergy Immunol; 2005 Jul; 137(3):219-28. PubMed ID: 15956790
[TBL] [Abstract][Full Text] [Related]
20. Prevention of acute allergic conjunctivitis and late-phase inflammation with immunostimulatory DNA sequences.
Miyazaki D; Liu G; Clark L; Ono SJ
Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3850-5. PubMed ID: 11053285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
